UPDATE : Thursday, September 12, 2019
상단여백
Huons Global hits record-high 1H sales by Lee Han-soo 2019-08-14 14:46
Court dismisses Kolon's petition to suspend government's step on Invossa by Lee Han-soo 2019-08-14 11:57
Hugel posts ₩50.3 billion in Q2 sales by Lee Han-soo 2019-08-13 18:13
Last trial OKed for Eylea to prevent blindness in premature infants by Lee Hye-seon 2019-08-13 12:42
Daewoong's idiopathic pulmonary fibrosis treatment wins orphan drug status by Lee Han-soo 2019-08-13 11:12
라인
Roche wins additional indication for breast cancer treatment Kadcyla by Lee Han-soo 2019-08-12 15:17
Yuhan can continue testing lung cancer drug Lazertinib by Lee Hye-seon 2019-08-12 12:58
Kolmar CEO steps down, apologizes for controversial video by Lee Han-soo 2019-08-12 11:11
Kolmar apologizes for playing controversial YouTube clip by Lee Han-soo 2019-08-09 16:48
Diabetes drug Jardiance pressures heart failure treatment Entresto by Kim Yun-mi 2019-08-09 15:44
라인
AstraZeneca’s Lynparza show positive results for prostate cancer in P3 trial by Lee Han-soo 2019-08-08 16:48
‘CPhI Korea thriving on local firms’ zeal for drug export’ by Jeong Sae-im 2019-08-08 14:54
Hanmi’s US partner unveils P3 data on oral anticancer drug by Lee Han-soo 2019-08-08 14:53
'Daewoong risk' could put a damper on AbbVie-Allergan mega-merger by Lee Han-soo 2019-08-07 16:22
Lilly’s anticancer combo drug nears getting insurance benefit by Kim Yun-mi 2019-08-07 15:44
라인
Lilly reports improved survival for Verzenio in P3 trial by Lee Han-soo 2019-08-07 12:06
ISU Abxis to unveil p1 results for anticancer treatment in Europe by Lee Han-soo 2019-08-07 12:03
Crystal Genomics signs accord with CRO firm by Lee Han-soo 2019-08-06 17:20
Japanese firms fear boycott may hurt prescription drug sales by Kim Yun-mi 2019-08-06 15:44
Sillajen cites salvation therapy as reason for trial suspension advice by Lee Han-soo 2019-08-06 15:43
여백
여백
여백
Back to Top